Stock Spotlight Archives - Page 144 of 348

ThursdayJun 24, 2021 1:26 pm

QualityStocksNewsBreaks – Healthtech Solutions Inc. (HLTT) Positioning at Leading Edge of Cancer Treatment

Healthtech Solutions (OTC: HLTT) is positioning itself to be a leader in the burgeoning precision oncology market — projected to grow at a 9.9% CAGR from 2019 to 2027 and reach an estimated $99.7 billion — as a result of its newest acquisition: Varian Biopharmaceuticals. Varian is a precision oncology company developing novel therapeutics for the treatment of cancer — a proprietary atypical protein kinase C iota (“aPKCi”) inhibitor for the treatment of various tumor types. Its drug candidates, VAR-101 and VAR-102, leverage the company’s expertise. According to HLTT chairman David Rubin, who was quoted by a recent article, “Varian…

WednesdayJun 23, 2021 3:10 pm

QualityStocksNewsBreaks – Friendable Inc. (FDBL) Finding New Ways to Reward and Incentivize Artists

Friendable (OTC: FDBL), a mobile technology and marketing company, recently entered an agreement with Santo Blockchain Labs and Santo Mining Corp for the development of global entertainment and musical artist-driven NFTs and the “Fanpasscrypto” marketplace. Each created NFT is a unique opportunity for a new revenue stream for artists and the two companies. A recent article reads: “Even with the upcoming NFT offering, Fan Pass is still finding ways to reward and incentivize artists, while other streaming companies are facing complaints over their revenue structures. Platforms like Apple and Spotify are taking heat because of how artist royalty distribution is…

WednesdayJun 23, 2021 2:55 pm

QualityStocksNewsBreaks – Healthy Extracts Inc. (HYEX) Focused on Greater Supplement Effectiveness

Healthy Extracts (OTCQB: HYEX) develops, sells and distributes proprietary products with proven health benefits through its portfolio of wholly owned subsidiaries that currently comprises Ultimate Brain Nutrients(TM) (“UBN”) and BergametNA(TM). UBN creates formulations that improve brain health while BergametNA develops powerfully proven supplements sourced from the Citrus Bergamot Superfruit(TM) (“bergamot”) and which target cardiovascular and immune health. “Bergamot has a host of health benefits as it is a source of high concentrations of polyphenolic flavanones, measured in terms of the bergamot polyphenolic fraction (‘BPF’),” reads a recent article. Dr. Gerald Haase, MD, a clinical professor of surgery at the University…

WednesdayJun 23, 2021 2:14 pm

QualityStocksNewsBreaks – Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Setting Stage for Strengthened Demand for Blue Light Cystoscopy

Imagin Medical (CSE: IME) (OTCQB: IMEXF) is working closely with manufacturing partner Lighthouse Imaging on its proprietary i/Blue Imaging System(TM) and is on target to conduct private demonstrations at the annual American Urology Association meeting set for early September. “The updated product design will incorporate changes intended to meet critical verification requirements established through benchmark testing of competitive systems and feedback from preliminary meetings with the FDA,” reads a recent article. “The additional testing and specification development focused on the contrast agent-induced fluorescence and the ability to replicate the clinical observations in bench-level settings. The sensitivity of the system can…

TuesdayJun 22, 2021 2:53 pm

QualityStocksNewsBreaks – Mobius Interactive Ltd. Levels Up to Enhance Player Experience

Mobius Interactive, an online esports and gaming operator, is leading with its esports product to take full advantage of the rapidly expanding global entertainment market. The global esports segment is on pace to nearly double its audience over the next six years to hit 646 million in 2023. As the audience grows, Mobius has leveled up to provide an engaging experience. “Mobius Interactive is committed to creating the ideal customer experience, using real-time CRM systems to ensure the entire player journey is optimized for entertainment,” reads a recent article. “Throughout its three diverse brands Mobius.bet, Club Double and Aragon Casino,…

TuesdayJun 22, 2021 2:42 pm

QualityStocksNewsBreaks – Why DSG Global Inc. (DSGT) Is ‘One to Watch’

DSG Global (OTCQB: DSGT) is an emerging global technology company with interconnecting businesses in rapidly growing market segments. A recent article discusses the company’s roots in the golf industry and move into road-ready electric vehicles for delivery in the third quarter of 2021. “In 2019, the company secured exclusive North America distribution rights for Jonway Automobile Co. road-ready electric vehicles (‘EVs’). Jonway, based in Zhejiang, China, began manufacturing new vehicles s in 2003 and today produces electric powered cars, trucks, vans, SUVs, and scooters. Jonway vehicles are exported to more than 80 countries and are built to comply with U.S.…

TuesdayJun 22, 2021 1:39 pm

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Committed to Driving Novel Treatments Forward with Key Focus on Berubicin

CNS Pharmaceuticals’ (NASDAQ: CNSP) lead drug candidate, Berubicin, is a novel anthracycline, the first of which to appear capable of crossing the blood-brain barrier based on limited clinical data. The company is currently developing Berubicin in the treatment of several serious brain and central nervous system oncological indications. CNS is set to commence patient enrollment in a potentially pivotal study to evaluate the efficacy of Berubicin for adult glioblastoma multiforme (“GBM”) in the second quarter. Additionally, its sublicensee partner in Poland, WPD Pharmaceuticals, will initiate a Phase 2 multicenter clinical trial of Berubicin in adult GBM patients and is also…

TuesdayJun 22, 2021 1:18 pm

QualityStocksNewsBreaks – XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Advancing Rotigotine Development Program for Parkinson’s

XPhyto Therapeutics (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT), a bioscience technology accelerator, recently announced its drug formulation and development, conducted primarily by its wholly owned German subsidiary, Vektor Pharma TF GmbH, are on schedule and continue to expand in scope. A recent article reads, “A Q1 trial announced in January 2021 and focusing on a human bioavailability pilot study of the Rotigotine transdermal patch for Parkinson’s Disease was completed in March 2021. Due to the favorable outcome of the study, the Rotigotine development program will be advanced to include a pivotal human trial.” The article, which documented XPhyto’s advancements so…

MondayJun 21, 2021 1:57 pm

QualityStocksNewsBreaks – Pac Roots Cannabis Corp. (CSE: PACR) (OTCQB: PACRF) (FSE: 4XM) on Mission to ‘Deliver the Finest Genetics to Canadians’

Pac Roots (CSE: PACR) (OTCQB: PACRF) (FSE: 4XM), a Canadian company dedicated to producing premium-quality strains and products by leveraging a genetics-focused approach, is committed to quality and excellence, as evidenced by its mantra: quality over quantity. “Pac Roots is focused on elite genetics development and maximizes the quality of its offerings by keeping yields and profit margins high,” reads a recent article. “The company also leverages key partnerships to ensure the superiority of its products. ‘Our mission is to deliver the finest genetics to Canadians,’ the company states. ‘Preserving the excellence of our elite strains while introducing the highest…

MondayJun 21, 2021 1:44 pm

QualityStocksNewsBreaks – RYAH Group Inc. (CSE: RYAH) Partnering to Improve Standard of Care, Provide Turnkey Solutions in Plant-Based Medicine

RYAH Group (CSE: RYAH), a connected device and big data and technology company, is working with doctors as well as government and university research centers to reduce the variations in treatment plans and trials. The company, which has developed and uses dose-measuring internet-of-things (“IoT”) devices to collect HIPPA-compliant data to improve future medical treatments, is guided by the need to transform patient care. Key to this focus is utilizing big data and AI to reshape how the world understands plant-based medicine. A recent article reads, “RYAH partners with doctors to improve the standard of care for patients and researchers to…

Site Search

Company Search

Category: Stock Spotlight